Metraipolis › archive › dc_4bc41a4afcf9
Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways,… — Europe PMC PMID:41446789
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41446789
- DOI
- 10.3389/fphar.2025.1661201
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T20:01:25.622Z
- SHA-256 of the archived text
84d8a9879eb96fa0e43d34a22344e30ca102454532d4deaa708c237c8c46994c- Stable URL of this page
https://metraipolis.com/documento/dc_4bc41a4afcf9
How to cite
Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways,… — Europe PMC PMID:41446789 — Europe PMC (en), https://europepmc.org/article/MED/41446789 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bc41a4afcf9 (Metraipolis archive dc_4bc41a4afcf9, sha256 84d8a9879eb96fa0e43d34a22344e30ca102454532d4deaa708c237c8c46994c)
BibTeX
@misc{dc4bc41a4afcf9,
title = {Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways,… — Europe PMC PMID:41446789},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41446789},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bc41a4afcf9; sha256 84d8a9879eb96fa0e43d34a22344e30ca102454532d4deaa708c237c8c46994c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41446789. Agents can read the archived copy with the MCP tool read_document.